Flash Therapy
Flash Therapy
Flash therapy is a non-invasive treatment using an external beam delivered in high doses, at ultra-high speeds (less than 1 second), and in one to three sessions. This new therapy represents an exciting and potentially promising new direction in the treatment of cancer. Working groups in the FlashForward Consortium will help identify preclinical study design for understanding this therapy, develop and share protocols that will enable a safe and quality clinical start for new users, and assist with regulatory and advocacy efforts.
Varian Forms FlashForward Consortium
PALO ALTO, Calif., Oct. 20, 2018 /PRNewswire/ -- To expand the encouraging preclinical and translational research already conducted by Varian (NYSE: VAR) and two of its clinical partners , Maryland Proton Treatment Center and Cincinnati Children's/UC Health Proton Therapy Center, on the value of ultra-high dose rate proton therapy for the treatment of cancer, the company has formed the FlashForward™ Consortium. With an initial thirteen members, the consortium is focused on preclinical research, clinical implementation and advocacy efforts of Flash therapy. The initial FlashForward Consortium members are: